SCNI · NASDAQ
Scinai Immunotherapeutics (SCNI) Stock Price & Fundamentals
Scinai Immunotherapeutics (SCNI) closed at $1,202.74 on Oct 9, 2026, down 0.25% from the previous close of $1,205.76.
Share price, past year
1Y +30.02%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,202.74 |
| Sep 30, 2026 | $1,211.14 |
| Aug 31, 2026 | $1,209.21 |
| Jul 31, 2026 | $1,188.09 |
| Jun 30, 2026 | $1,190.41 |
| May 29, 2026 | $1,110.24 |
| Apr 30, 2026 | $1,137.38 |
| Mar 31, 2026 | $1,094.66 |
| Feb 27, 2026 | $1,091.36 |
| Jan 30, 2026 | $1,027.07 |
| Dec 31, 2025 | $1,005.21 |
| Nov 28, 2025 | $995.05 |
| Oct 31, 2025 | $976.28 |
Key statistics
- Market cap
- $16.69T
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 13.9B
- Dividend yield
- —
- 52-week range
- $925.04 – $1,253.03
Scinai Immunotherapeutics's market cap is $16.69T, based on a share price of $1,202.74 and 13.9B shares outstanding as of Dec 31, 2025.
Financials
Scinai Immunotherapeutics reported revenue of $1.31M for fiscal 2025, up 99.24% from fiscal 2024.
Scinai Immunotherapeutics reported a net loss of $8.31M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.31M | +99.2% | −$8.31M | −633.6% | — | −$6.06M |
| FY2024ended Dec 31, 2024 | $658.00K | — | $4.80M | 728.9% | — | −$6.35M |
Company profile
- Name
- Scinai Immunotherapeutics Ltd.
- Ticker
- SCNI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Jerusalem Biopark, 2nd Floor, Hadassah Ein Kerem Campus, Jerusalem, L3 00000
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001611747
Recent SEC filings
- Jun 8, 2023
- May 15, 2023
- May 11, 2023
- May 4, 2023
- May 4, 2023
- Apr 17, 2023
Frequently asked questions
What is Scinai Immunotherapeutics's stock price?
Scinai Immunotherapeutics (SCNI) closed at $1,202.74 on Oct 9, 2026, down 0.25% from the previous close of $1,205.76.
What is Scinai Immunotherapeutics's market cap?
Scinai Immunotherapeutics's market cap is $16.69T, based on a share price of $1,202.74 and 13.9B shares outstanding as of Dec 31, 2025.
How much revenue does Scinai Immunotherapeutics make?
Scinai Immunotherapeutics reported revenue of $1.31M for fiscal 2025, up 99.24% from fiscal 2024.
Sources and methodology
Fundamentals come from Scinai Immunotherapeutics Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures